Clinical Trials Browser

Completed × cemiplimab × Tumor-Agnostic × Clear all

NCT03005782 2024-05-01

Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers

Phase 1 Completed

Neoplasms

NCT05302297 2022-12-13

TOSCA

Neoplasms